Elizabeth Kovacs
Concepts (552)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Burns | 60 | 2025 | 284 | 17.710 |
Why?
| Ethanol | 54 | 2025 | 587 | 8.900 |
Why?
| Alcoholic Intoxication | 15 | 2023 | 63 | 5.780 |
Why?
| Alcohol Drinking | 25 | 2025 | 759 | 5.060 |
Why?
| Pneumonia | 13 | 2025 | 613 | 4.220 |
Why?
| Inflammation | 32 | 2025 | 2723 | 3.930 |
Why?
| Aging | 25 | 2025 | 1774 | 3.630 |
Why?
| Alcoholism | 22 | 2024 | 766 | 3.220 |
Why?
| Gastrointestinal Microbiome | 9 | 2025 | 640 | 3.090 |
Why?
| Lung Transplantation | 15 | 2019 | 289 | 2.770 |
Why?
| Immunity, Innate | 12 | 2017 | 804 | 2.590 |
Why?
| Interleukin-6 | 16 | 2023 | 720 | 2.420 |
Why?
| Cytokines | 20 | 2025 | 2011 | 2.340 |
Why?
| Feces | 4 | 2025 | 440 | 2.200 |
Why?
| Macrophages, Alveolar | 9 | 2022 | 389 | 2.130 |
Why?
| Neutrophils | 16 | 2022 | 1202 | 2.130 |
Why?
| Lung | 24 | 2024 | 3916 | 2.110 |
Why?
| Liver Diseases | 5 | 2021 | 288 | 2.040 |
Why?
| Dysbiosis | 5 | 2025 | 167 | 2.020 |
Why?
| Burns, Inhalation | 5 | 2020 | 9 | 1.960 |
Why?
| Mice | 66 | 2025 | 16861 | 1.950 |
Why?
| Intestines | 4 | 2022 | 347 | 1.950 |
Why?
| Binge Drinking | 8 | 2023 | 36 | 1.920 |
Why?
| Animals | 95 | 2025 | 35219 | 1.860 |
Why?
| Wound Healing | 11 | 2015 | 303 | 1.860 |
Why?
| Macrophages | 13 | 2016 | 1478 | 1.770 |
Why?
| Mice, Inbred C57BL | 35 | 2025 | 5408 | 1.750 |
Why?
| Gastroesophageal Reflux | 10 | 2014 | 229 | 1.740 |
Why?
| Glycerophospholipids | 6 | 2025 | 34 | 1.730 |
Why?
| Bronchoalveolar Lavage Fluid | 15 | 2018 | 642 | 1.660 |
Why?
| Lung Diseases | 9 | 2018 | 741 | 1.580 |
Why?
| Age Factors | 17 | 2025 | 3137 | 1.580 |
Why?
| Phagocytosis | 7 | 2016 | 361 | 1.410 |
Why?
| Smoke Inhalation Injury | 6 | 2013 | 23 | 1.370 |
Why?
| Neutrophil Infiltration | 8 | 2016 | 105 | 1.320 |
Why?
| Respiratory Aspiration | 4 | 2013 | 31 | 1.240 |
Why?
| Bacterial Translocation | 6 | 2016 | 40 | 1.230 |
Why?
| Public Opinion | 4 | 2023 | 63 | 1.210 |
Why?
| Disease Models, Animal | 21 | 2025 | 4049 | 1.200 |
Why?
| Pseudomonas Infections | 4 | 2016 | 220 | 1.150 |
Why?
| Central Nervous System Depressants | 3 | 2015 | 82 | 1.120 |
Why?
| Macrophage Activation | 6 | 2019 | 188 | 1.120 |
Why?
| Immune System | 5 | 2017 | 175 | 1.030 |
Why?
| Bronchiolitis Obliterans | 6 | 2014 | 68 | 1.010 |
Why?
| Male | 78 | 2025 | 63498 | 0.980 |
Why?
| Liver | 10 | 2025 | 1838 | 0.970 |
Why?
| Radiation Injuries, Experimental | 3 | 2013 | 22 | 0.960 |
Why?
| Wound Infection | 2 | 2016 | 29 | 0.940 |
Why?
| Fatty Acid-Binding Proteins | 1 | 2025 | 69 | 0.940 |
Why?
| Pneumonia, Bacterial | 2 | 2016 | 112 | 0.890 |
Why?
| Postoperative Complications | 6 | 2018 | 2476 | 0.850 |
Why?
| Humans | 100 | 2025 | 129219 | 0.840 |
Why?
| Skin | 6 | 2016 | 721 | 0.840 |
Why?
| Mice, Inbred BALB C | 12 | 2020 | 1243 | 0.830 |
Why?
| Radiation Injuries | 2 | 2016 | 135 | 0.800 |
Why?
| Chemokines | 8 | 2023 | 225 | 0.790 |
Why?
| Biomedical Research | 4 | 2018 | 637 | 0.780 |
Why?
| Biomarkers | 19 | 2024 | 3968 | 0.780 |
Why?
| Pneumonia, Pneumococcal | 1 | 2022 | 42 | 0.760 |
Why?
| Delirium | 1 | 2023 | 78 | 0.750 |
Why?
| Wounds and Injuries | 4 | 2015 | 708 | 0.740 |
Why?
| Signal Transduction | 14 | 2022 | 4913 | 0.730 |
Why?
| Tight Junctions | 1 | 2021 | 74 | 0.730 |
Why?
| Female | 61 | 2025 | 68607 | 0.720 |
Why?
| Pneumococcal Infections | 1 | 2022 | 110 | 0.710 |
Why?
| Immunity, Cellular | 5 | 2018 | 264 | 0.710 |
Why?
| Astrocytes | 1 | 2022 | 199 | 0.700 |
Why?
| Leukocytes | 3 | 2011 | 303 | 0.670 |
Why?
| Estrogens | 2 | 2016 | 346 | 0.670 |
Why?
| Pore Forming Cytotoxic Proteins | 1 | 2020 | 16 | 0.670 |
Why?
| von Willebrand Factor | 1 | 2019 | 70 | 0.640 |
Why?
| Intestinal Mucosa | 3 | 2021 | 590 | 0.640 |
Why?
| Allergy and Immunology | 2 | 2017 | 43 | 0.630 |
Why?
| Gastrointestinal Tract | 2 | 2020 | 184 | 0.620 |
Why?
| Fatty Liver | 3 | 2017 | 231 | 0.610 |
Why?
| Hepatitis, Alcoholic | 1 | 2018 | 13 | 0.610 |
Why?
| Epigenesis, Genetic | 4 | 2022 | 613 | 0.600 |
Why?
| Immunosenescence | 2 | 2017 | 4 | 0.600 |
Why?
| Pseudomonas aeruginosa | 5 | 2014 | 346 | 0.600 |
Why?
| Tumor Necrosis Factor-alpha | 6 | 2022 | 1195 | 0.600 |
Why?
| Pepsin A | 3 | 2014 | 19 | 0.590 |
Why?
| Mesenchymal Stem Cell Transplantation | 1 | 2018 | 50 | 0.590 |
Why?
| Flow Cytometry | 6 | 2018 | 1156 | 0.590 |
Why?
| Immunity | 3 | 2025 | 139 | 0.580 |
Why?
| Chemokine CCL2 | 1 | 2017 | 118 | 0.550 |
Why?
| Aged | 24 | 2024 | 22030 | 0.540 |
Why?
| Sepsis | 5 | 2023 | 571 | 0.540 |
Why?
| Histone Deacetylase 1 | 1 | 2016 | 24 | 0.530 |
Why?
| Tissue Donors | 3 | 2018 | 391 | 0.530 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2023 | 569 | 0.530 |
Why?
| Length of Stay | 3 | 2019 | 1121 | 0.520 |
Why?
| Kupffer Cells | 1 | 2016 | 49 | 0.520 |
Why?
| Spleen | 5 | 2011 | 506 | 0.520 |
Why?
| Myosin-Light-Chain Kinase | 2 | 2014 | 20 | 0.510 |
Why?
| Middle Aged | 30 | 2024 | 31075 | 0.510 |
Why?
| Pulmonary Edema | 1 | 2016 | 106 | 0.510 |
Why?
| Inflammation Mediators | 6 | 2015 | 505 | 0.500 |
Why?
| Laparoscopy | 5 | 2014 | 451 | 0.500 |
Why?
| Granulocyte Colony-Stimulating Factor | 2 | 2013 | 72 | 0.500 |
Why?
| Adaptive Immunity | 2 | 2016 | 160 | 0.490 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 274 | 0.490 |
Why?
| Microbiota | 1 | 2023 | 725 | 0.490 |
Why?
| Intestine, Small | 2 | 2016 | 150 | 0.490 |
Why?
| Bradykinin B2 Receptor Antagonists | 1 | 2015 | 1 | 0.480 |
Why?
| Oxidative Stress | 6 | 2025 | 1268 | 0.470 |
Why?
| Bradykinin | 1 | 2015 | 45 | 0.470 |
Why?
| Immunologic Memory | 1 | 2017 | 349 | 0.470 |
Why?
| Extracellular Traps | 1 | 2015 | 46 | 0.470 |
Why?
| Models, Animal | 6 | 2019 | 373 | 0.470 |
Why?
| Dehydration | 1 | 2015 | 49 | 0.460 |
Why?
| Respiration | 1 | 2015 | 191 | 0.460 |
Why?
| Primary Graft Dysfunction | 1 | 2014 | 29 | 0.460 |
Why?
| Adult | 32 | 2025 | 35471 | 0.450 |
Why?
| Esophageal pH Monitoring | 1 | 2014 | 23 | 0.450 |
Why?
| Histones | 2 | 2016 | 588 | 0.440 |
Why?
| Lipopolysaccharides | 5 | 2012 | 871 | 0.440 |
Why?
| Breath Tests | 3 | 2016 | 89 | 0.440 |
Why?
| Monocytes | 1 | 2016 | 551 | 0.420 |
Why?
| Congresses as Topic | 4 | 2020 | 214 | 0.420 |
Why?
| Scleroderma, Systemic | 1 | 2014 | 108 | 0.420 |
Why?
| Research Personnel | 1 | 2014 | 156 | 0.410 |
Why?
| Dendritic Cells | 3 | 2016 | 477 | 0.410 |
Why?
| Ileitis | 1 | 2013 | 33 | 0.410 |
Why?
| Permeability | 3 | 2022 | 157 | 0.400 |
Why?
| Solvents | 1 | 2013 | 108 | 0.400 |
Why?
| Mentors | 1 | 2014 | 178 | 0.400 |
Why?
| Chemotaxis, Leukocyte | 1 | 2013 | 137 | 0.400 |
Why?
| Career Choice | 1 | 2014 | 207 | 0.400 |
Why?
| Graft Rejection | 2 | 2013 | 597 | 0.390 |
Why?
| Intestinal Diseases | 1 | 2012 | 36 | 0.390 |
Why?
| Leukocyte Count | 5 | 2013 | 325 | 0.390 |
Why?
| Injury Severity Score | 5 | 2017 | 509 | 0.390 |
Why?
| rac GTP-Binding Proteins | 1 | 2012 | 32 | 0.390 |
Why?
| Phagosomes | 1 | 2012 | 42 | 0.380 |
Why?
| Fundoplication | 1 | 2012 | 54 | 0.380 |
Why?
| Receptors, IgG | 1 | 2012 | 74 | 0.380 |
Why?
| Staphylococcal Infections | 2 | 2013 | 392 | 0.380 |
Why?
| Risk Factors | 12 | 2025 | 9747 | 0.380 |
Why?
| Antibodies | 2 | 2013 | 397 | 0.370 |
Why?
| Ischemia | 1 | 2015 | 406 | 0.370 |
Why?
| Alanine Transaminase | 4 | 2021 | 152 | 0.370 |
Why?
| Toll-Like Receptor 4 | 2 | 2010 | 263 | 0.370 |
Why?
| Prospective Studies | 9 | 2021 | 7103 | 0.370 |
Why?
| Immunologic Factors | 2 | 2016 | 231 | 0.360 |
Why?
| Logistic Models | 6 | 2019 | 1983 | 0.360 |
Why?
| Ligands | 2 | 2023 | 621 | 0.360 |
Why?
| Enzyme-Linked Immunosorbent Assay | 9 | 2018 | 832 | 0.350 |
Why?
| Mice, Knockout | 7 | 2013 | 2856 | 0.350 |
Why?
| Down-Regulation | 1 | 2013 | 636 | 0.340 |
Why?
| Cause of Death | 3 | 2019 | 392 | 0.340 |
Why?
| Cell Separation | 1 | 2011 | 316 | 0.340 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 135 | 0.330 |
Why?
| Respiratory Function Tests | 3 | 2025 | 585 | 0.330 |
Why?
| Toll-Like Receptor 2 | 1 | 2010 | 113 | 0.330 |
Why?
| Actins | 1 | 2012 | 408 | 0.320 |
Why?
| Environmental Pollutants | 1 | 2011 | 142 | 0.320 |
Why?
| Protein Precursors | 2 | 2025 | 127 | 0.320 |
Why?
| Immune Tolerance | 1 | 2012 | 354 | 0.320 |
Why?
| Ileum | 2 | 2024 | 116 | 0.320 |
Why?
| Receptors, Interleukin-8B | 2 | 2010 | 24 | 0.320 |
Why?
| Interleukin-12 | 2 | 2013 | 118 | 0.310 |
Why?
| Illinois | 4 | 2017 | 39 | 0.300 |
Why?
| Occludin | 2 | 2021 | 11 | 0.300 |
Why?
| Time Factors | 9 | 2019 | 6549 | 0.290 |
Why?
| Chemokine CXCL1 | 2 | 2020 | 73 | 0.280 |
Why?
| Aspartate Aminotransferases | 2 | 2021 | 87 | 0.280 |
Why?
| Smoking | 2 | 2013 | 1499 | 0.280 |
Why?
| Respiration, Artificial | 1 | 2012 | 609 | 0.280 |
Why?
| Apoptosis | 6 | 2025 | 2501 | 0.280 |
Why?
| Bronchoscopy | 3 | 2013 | 211 | 0.280 |
Why?
| Young Adult | 9 | 2025 | 12403 | 0.280 |
Why?
| Plethysmography | 2 | 2019 | 107 | 0.280 |
Why?
| Gastroenteritis | 1 | 2008 | 67 | 0.280 |
Why?
| Peptides | 1 | 2012 | 924 | 0.270 |
Why?
| Peroxidase | 3 | 2016 | 173 | 0.270 |
Why?
| Trachea | 1 | 2008 | 220 | 0.260 |
Why?
| Statistics, Nonparametric | 5 | 2013 | 421 | 0.250 |
Why?
| Cholera Toxin | 1 | 2025 | 31 | 0.240 |
Why?
| Bacteria | 3 | 2023 | 815 | 0.240 |
Why?
| Skin Ulcer | 2 | 2015 | 13 | 0.240 |
Why?
| Retrospective Studies | 10 | 2023 | 14488 | 0.240 |
Why?
| Haptoglobins | 1 | 2025 | 52 | 0.240 |
Why?
| Bacteroidetes | 1 | 2024 | 23 | 0.230 |
Why?
| Fecal Microbiota Transplantation | 1 | 2024 | 20 | 0.230 |
Why?
| Mitochondria, Liver | 1 | 2025 | 74 | 0.230 |
Why?
| Aged, 80 and over | 5 | 2017 | 7061 | 0.230 |
Why?
| Survival Analysis | 3 | 2019 | 1271 | 0.220 |
Why?
| ROC Curve | 5 | 2018 | 503 | 0.220 |
Why?
| Exhalation | 2 | 2016 | 38 | 0.220 |
Why?
| Burn Units | 2 | 2022 | 42 | 0.220 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 149 | 0.220 |
Why?
| Hospital Mortality | 2 | 2019 | 850 | 0.220 |
Why?
| Toxoplasma | 1 | 2024 | 37 | 0.220 |
Why?
| Toxoplasmosis | 1 | 2024 | 36 | 0.220 |
Why?
| Fatty Acids, Volatile | 1 | 2024 | 57 | 0.220 |
Why?
| Cohort Studies | 9 | 2019 | 5408 | 0.220 |
Why?
| Homeostasis | 2 | 2020 | 611 | 0.220 |
Why?
| Hepatocytes | 1 | 2025 | 216 | 0.210 |
Why?
| Multivariate Analysis | 3 | 2023 | 1500 | 0.210 |
Why?
| Hawaii | 1 | 2023 | 32 | 0.210 |
Why?
| Zonula Occludens-1 Protein | 2 | 2013 | 15 | 0.210 |
Why?
| alpha-Defensins | 1 | 2022 | 10 | 0.200 |
Why?
| Whole-Body Irradiation | 2 | 2013 | 76 | 0.200 |
Why?
| Phenotype | 4 | 2020 | 3074 | 0.200 |
Why?
| Body Surface Area | 1 | 2022 | 33 | 0.200 |
Why?
| Sex Characteristics | 3 | 2016 | 732 | 0.200 |
Why?
| Mitochondrial Proteins | 1 | 2025 | 246 | 0.200 |
Why?
| Veterans | 2 | 2024 | 1397 | 0.200 |
Why?
| Veterans Health | 1 | 2024 | 178 | 0.190 |
Why?
| Caspases | 1 | 2023 | 245 | 0.190 |
Why?
| Neurodegenerative Diseases | 1 | 2023 | 112 | 0.190 |
Why?
| Critical Illness | 2 | 2018 | 756 | 0.190 |
Why?
| Fluorescent Antibody Technique | 3 | 2014 | 376 | 0.190 |
Why?
| Interleukin-1beta | 3 | 2020 | 372 | 0.190 |
Why?
| Malondialdehyde | 1 | 2021 | 28 | 0.180 |
Why?
| Colon | 1 | 2023 | 252 | 0.180 |
Why?
| Interleukins | 2 | 2014 | 241 | 0.180 |
Why?
| NF-kappa B | 1 | 2025 | 653 | 0.180 |
Why?
| Injections, Intraperitoneal | 2 | 2013 | 110 | 0.180 |
Why?
| Hippocampus | 2 | 2025 | 856 | 0.180 |
Why?
| Frailty | 1 | 2024 | 153 | 0.180 |
Why?
| Phosphorylation | 3 | 2016 | 1710 | 0.180 |
Why?
| Nanoparticles | 1 | 2025 | 373 | 0.180 |
Why?
| Lipid Peroxidation | 1 | 2021 | 151 | 0.180 |
Why?
| Analysis of Variance | 3 | 2014 | 1285 | 0.170 |
Why?
| Streptococcus pneumoniae | 1 | 2022 | 159 | 0.170 |
Why?
| Ventricular Dysfunction, Right | 1 | 2023 | 231 | 0.170 |
Why?
| Caspase 3 | 3 | 2023 | 244 | 0.170 |
Why?
| Boston | 1 | 2020 | 87 | 0.170 |
Why?
| Air Pollutants | 1 | 2024 | 312 | 0.170 |
Why?
| Organ Specificity | 1 | 2020 | 295 | 0.170 |
Why?
| Resistin | 1 | 2019 | 11 | 0.170 |
Why?
| Gastric Inhibitory Polypeptide | 1 | 2019 | 23 | 0.160 |
Why?
| Ghrelin | 1 | 2019 | 33 | 0.160 |
Why?
| Cells, Cultured | 7 | 2016 | 4072 | 0.160 |
Why?
| Metformin | 1 | 2023 | 315 | 0.160 |
Why?
| Mannose-Binding Lectins | 1 | 2019 | 11 | 0.160 |
Why?
| Predictive Value of Tests | 3 | 2019 | 1944 | 0.160 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2019 | 84 | 0.160 |
Why?
| Risk Assessment | 5 | 2019 | 3234 | 0.160 |
Why?
| Natural Killer T-Cells | 2 | 2010 | 65 | 0.160 |
Why?
| Glutathione | 1 | 2021 | 348 | 0.160 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2010 | 146 | 0.160 |
Why?
| Lectins, C-Type | 1 | 2019 | 71 | 0.160 |
Why?
| Life Style | 2 | 2014 | 460 | 0.160 |
Why?
| Fires | 1 | 2020 | 88 | 0.160 |
Why?
| Cell Count | 2 | 2016 | 314 | 0.150 |
Why?
| Cognitive Dysfunction | 1 | 2023 | 345 | 0.150 |
Why?
| Multiple Organ Failure | 2 | 2017 | 122 | 0.150 |
Why?
| Administration, Oral | 2 | 2013 | 783 | 0.150 |
Why?
| In Situ Nick-End Labeling | 1 | 2018 | 124 | 0.150 |
Why?
| Glucagon-Like Peptide 1 | 1 | 2019 | 112 | 0.150 |
Why?
| Prognosis | 3 | 2018 | 3791 | 0.150 |
Why?
| Antimicrobial Cationic Peptides | 1 | 2018 | 77 | 0.150 |
Why?
| Leptin | 1 | 2019 | 218 | 0.150 |
Why?
| Toll-Like Receptors | 2 | 2009 | 179 | 0.140 |
Why?
| Intensive Care Units | 4 | 2019 | 735 | 0.140 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 958 | 0.140 |
Why?
| Mental Health | 1 | 2024 | 685 | 0.140 |
Why?
| RNA, Ribosomal, 16S | 1 | 2020 | 521 | 0.140 |
Why?
| Reproducibility of Results | 2 | 2019 | 3067 | 0.140 |
Why?
| Needs Assessment | 1 | 2019 | 360 | 0.140 |
Why?
| Transcriptome | 1 | 2023 | 885 | 0.140 |
Why?
| Tobacco Use | 1 | 2017 | 61 | 0.140 |
Why?
| Receptors, Cell Surface | 1 | 2019 | 378 | 0.140 |
Why?
| United States | 10 | 2024 | 13873 | 0.130 |
Why?
| Follow-Up Studies | 2 | 2018 | 4886 | 0.130 |
Why?
| Incidence | 3 | 2019 | 2638 | 0.130 |
Why?
| Phylogeny | 1 | 2020 | 849 | 0.130 |
Why?
| Ovariectomy | 1 | 2016 | 136 | 0.130 |
Why?
| Monocyte Chemoattractant Proteins | 1 | 2015 | 8 | 0.120 |
Why?
| Chemokine CXCL2 | 1 | 2015 | 43 | 0.120 |
Why?
| Acetylation | 1 | 2016 | 246 | 0.120 |
Why?
| Dose-Response Relationship, Drug | 3 | 2010 | 2003 | 0.120 |
Why?
| Apicomplexa | 1 | 2015 | 2 | 0.120 |
Why?
| Polymerase Chain Reaction | 1 | 2018 | 1036 | 0.120 |
Why?
| Regression Analysis | 3 | 2013 | 993 | 0.120 |
Why?
| Imidazoles | 1 | 2016 | 234 | 0.120 |
Why?
| Linear Models | 1 | 2017 | 818 | 0.120 |
Why?
| Cognition | 1 | 2023 | 1114 | 0.120 |
Why?
| Negative-Pressure Wound Therapy | 1 | 2015 | 21 | 0.120 |
Why?
| Enzyme Inhibitors | 2 | 2016 | 826 | 0.120 |
Why?
| Killer Cells, Natural | 2 | 2008 | 426 | 0.120 |
Why?
| Insulin | 2 | 2019 | 2324 | 0.120 |
Why?
| Hematocrit | 1 | 2015 | 93 | 0.120 |
Why?
| Radiation Dosage | 1 | 2016 | 153 | 0.120 |
Why?
| Wasting Syndrome | 1 | 2014 | 12 | 0.120 |
Why?
| Electric Stimulation Therapy | 1 | 2015 | 58 | 0.110 |
Why?
| Respiratory Tract Diseases | 1 | 2016 | 148 | 0.110 |
Why?
| Gene Expression | 2 | 2018 | 1469 | 0.110 |
Why?
| Systemic Inflammatory Response Syndrome | 2 | 2014 | 85 | 0.110 |
Why?
| Alcohol-Related Disorders | 1 | 2015 | 118 | 0.110 |
Why?
| Leukocyte Disorders | 1 | 2014 | 10 | 0.110 |
Why?
| Chi-Square Distribution | 2 | 2013 | 515 | 0.110 |
Why?
| Interleukin-23 | 1 | 2014 | 19 | 0.110 |
Why?
| Viruses | 1 | 2015 | 100 | 0.110 |
Why?
| Sex Factors | 4 | 2019 | 1961 | 0.110 |
Why?
| Fungi | 1 | 2015 | 135 | 0.110 |
Why?
| Caspase 8 | 1 | 2013 | 48 | 0.110 |
Why?
| Lung Injury | 1 | 2016 | 210 | 0.110 |
Why?
| Immune System Diseases | 1 | 2014 | 34 | 0.110 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2014 | 51 | 0.110 |
Why?
| Faculty | 1 | 2014 | 136 | 0.110 |
Why?
| Lymphocyte Subsets | 1 | 2013 | 84 | 0.110 |
Why?
| Th17 Cells | 1 | 2014 | 83 | 0.100 |
Why?
| Myosin Light Chains | 1 | 2013 | 27 | 0.100 |
Why?
| Adipose Tissue | 2 | 2015 | 590 | 0.100 |
Why?
| Pyridines | 1 | 2016 | 478 | 0.100 |
Why?
| Employment | 1 | 2014 | 167 | 0.100 |
Why?
| Creatinine | 1 | 2015 | 490 | 0.100 |
Why?
| Immunoassay | 1 | 2013 | 107 | 0.100 |
Why?
| Calcitonin | 1 | 2012 | 27 | 0.100 |
Why?
| Bile Acids and Salts | 1 | 2014 | 195 | 0.100 |
Why?
| Bacterial Load | 1 | 2012 | 66 | 0.100 |
Why?
| Syndrome | 1 | 2013 | 339 | 0.100 |
Why?
| Vinculin | 1 | 2012 | 10 | 0.100 |
Why?
| Anti-Infective Agents | 1 | 2015 | 246 | 0.100 |
Why?
| Paxillin | 1 | 2012 | 10 | 0.100 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 2013 | 252 | 0.100 |
Why?
| Receptors, Interleukin-4 | 1 | 2011 | 15 | 0.100 |
Why?
| Pregnancy | 2 | 2023 | 6384 | 0.100 |
Why?
| Cell Differentiation | 2 | 2016 | 1899 | 0.100 |
Why?
| Decidua | 1 | 1992 | 23 | 0.100 |
Why?
| Chorionic Villi | 1 | 1992 | 22 | 0.100 |
Why?
| Receptors, Interleukin-2 | 1 | 1992 | 66 | 0.090 |
Why?
| Focal Adhesions | 1 | 2012 | 44 | 0.090 |
Why?
| Ubiquitin | 1 | 2012 | 63 | 0.090 |
Why?
| Chemokine CXCL12 | 1 | 2012 | 79 | 0.090 |
Why?
| Hypertension, Pulmonary | 1 | 2023 | 1891 | 0.090 |
Why?
| rho GTP-Binding Proteins | 1 | 2012 | 61 | 0.090 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2011 | 171 | 0.090 |
Why?
| Blood Glucose | 2 | 2019 | 2094 | 0.090 |
Why?
| Polymerization | 1 | 2012 | 124 | 0.090 |
Why?
| Vehicle Emissions | 1 | 2011 | 56 | 0.090 |
Why?
| Research Support as Topic | 1 | 2012 | 111 | 0.090 |
Why?
| Confidence Intervals | 1 | 2012 | 317 | 0.090 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 287 | 0.090 |
Why?
| Phagocytes | 2 | 2009 | 97 | 0.090 |
Why?
| Pulmonary Alveoli | 1 | 2013 | 399 | 0.090 |
Why?
| Specimen Handling | 1 | 2012 | 163 | 0.090 |
Why?
| Cytoskeleton | 1 | 2012 | 182 | 0.090 |
Why?
| Tissue Engineering | 1 | 2015 | 396 | 0.090 |
Why?
| Bone Marrow Cells | 1 | 2011 | 297 | 0.090 |
Why?
| Nitric Oxide | 1 | 2016 | 899 | 0.090 |
Why?
| Edema | 1 | 2011 | 124 | 0.090 |
Why?
| Body Composition | 1 | 2014 | 649 | 0.090 |
Why?
| Writing | 1 | 2012 | 91 | 0.090 |
Why?
| Ozone | 1 | 2011 | 103 | 0.090 |
Why?
| Immunohistochemistry | 1 | 2015 | 1696 | 0.090 |
Why?
| Dermatitis | 1 | 2010 | 19 | 0.090 |
Why?
| Equipment Design | 1 | 2012 | 513 | 0.080 |
Why?
| Bacteremia | 1 | 2012 | 197 | 0.080 |
Why?
| Heart Failure | 1 | 2023 | 2147 | 0.080 |
Why?
| DNA | 2 | 2015 | 1399 | 0.080 |
Why?
| Trophoblasts | 1 | 1992 | 190 | 0.080 |
Why?
| Adolescent | 5 | 2017 | 20378 | 0.080 |
Why?
| Mass Screening | 2 | 2015 | 1147 | 0.080 |
Why?
| Cystic Fibrosis | 1 | 2019 | 1050 | 0.080 |
Why?
| Adiposity | 1 | 2014 | 504 | 0.080 |
Why?
| Endoscopy, Gastrointestinal | 1 | 2011 | 217 | 0.080 |
Why?
| Respiration Disorders | 1 | 2010 | 72 | 0.080 |
Why?
| Interleukin-18 | 1 | 2010 | 236 | 0.080 |
Why?
| Odds Ratio | 1 | 2012 | 1023 | 0.080 |
Why?
| Severity of Illness Index | 2 | 2019 | 2736 | 0.080 |
Why?
| Acute Lung Injury | 1 | 2012 | 278 | 0.080 |
Why?
| Histiocytes | 1 | 2008 | 7 | 0.080 |
Why?
| Kaplan-Meier Estimate | 1 | 2011 | 857 | 0.080 |
Why?
| Escherichia coli K12 | 1 | 2008 | 7 | 0.080 |
Why?
| Membrane Fluidity | 1 | 2008 | 11 | 0.070 |
Why?
| Hypersensitivity, Delayed | 1 | 2008 | 28 | 0.070 |
Why?
| Protein Kinase Inhibitors | 1 | 2014 | 889 | 0.070 |
Why?
| Membrane Microdomains | 1 | 2008 | 32 | 0.070 |
Why?
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 14 | 0.070 |
Why?
| Interleukin-2 | 1 | 2009 | 436 | 0.070 |
Why?
| Shock | 1 | 2009 | 92 | 0.070 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 84 | 0.070 |
Why?
| Comorbidity | 3 | 2019 | 1545 | 0.070 |
Why?
| Manometry | 3 | 2013 | 90 | 0.070 |
Why?
| Opportunistic Infections | 1 | 2008 | 46 | 0.070 |
Why?
| Cell Survival | 2 | 2025 | 1085 | 0.070 |
Why?
| Capillary Permeability | 1 | 2008 | 138 | 0.070 |
Why?
| Testis | 1 | 2008 | 144 | 0.070 |
Why?
| Intubation, Gastrointestinal | 1 | 2008 | 77 | 0.070 |
Why?
| Pediatric Obesity | 1 | 2014 | 570 | 0.070 |
Why?
| Survival Rate | 1 | 2012 | 1874 | 0.070 |
Why?
| Staphylococcus aureus | 1 | 2011 | 436 | 0.070 |
Why?
| Protein Kinases | 1 | 2009 | 318 | 0.070 |
Why?
| Mast Cells | 1 | 2008 | 142 | 0.070 |
Why?
| Neovascularization, Physiologic | 1 | 2008 | 176 | 0.070 |
Why?
| Hypothalamo-Hypophyseal System | 1 | 2008 | 180 | 0.070 |
Why?
| Diet | 1 | 2014 | 1212 | 0.070 |
Why?
| Gonadal Steroid Hormones | 1 | 2008 | 130 | 0.070 |
Why?
| Hydrogen-Ion Concentration | 3 | 2013 | 543 | 0.070 |
Why?
| Angiogenesis Inhibitors | 1 | 2008 | 219 | 0.070 |
Why?
| Reproduction | 1 | 2008 | 197 | 0.060 |
Why?
| In Vitro Techniques | 1 | 2008 | 1083 | 0.060 |
Why?
| Asthma | 2 | 2016 | 2222 | 0.060 |
Why?
| Interleukin-1 | 1 | 2010 | 958 | 0.060 |
Why?
| Cell Line | 1 | 2012 | 2777 | 0.060 |
Why?
| Interferon-gamma | 1 | 2009 | 769 | 0.060 |
Why?
| Cell Communication | 1 | 2008 | 300 | 0.060 |
Why?
| Treatment Outcome | 2 | 2012 | 10189 | 0.060 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2013 | 629 | 0.060 |
Why?
| Research Design | 1 | 2012 | 1038 | 0.060 |
Why?
| Eosinophils | 1 | 2008 | 323 | 0.060 |
Why?
| Sensitivity and Specificity | 3 | 2018 | 1834 | 0.060 |
Why?
| Reference Values | 2 | 2019 | 793 | 0.060 |
Why?
| Serum Amyloid A Protein | 1 | 2025 | 31 | 0.060 |
Why?
| Neoplasms | 2 | 2016 | 2467 | 0.060 |
Why?
| Acute Disease | 1 | 2008 | 977 | 0.060 |
Why?
| Barrett Esophagus | 3 | 2012 | 144 | 0.060 |
Why?
| Polymorphism, Genetic | 1 | 2008 | 640 | 0.060 |
Why?
| Hemorrhage | 1 | 2009 | 677 | 0.060 |
Why?
| Lomustine | 1 | 2024 | 14 | 0.060 |
Why?
| Anti-Bacterial Agents | 1 | 2014 | 1711 | 0.060 |
Why?
| Antioxidants | 1 | 2008 | 557 | 0.060 |
Why?
| Anti-Inflammatory Agents | 1 | 2008 | 478 | 0.060 |
Why?
| Antibodies, Protozoan | 1 | 2024 | 31 | 0.060 |
Why?
| Gene Silencing | 1 | 2025 | 187 | 0.050 |
Why?
| Metals, Heavy | 1 | 2024 | 30 | 0.050 |
Why?
| Inflammasomes | 1 | 2025 | 126 | 0.050 |
Why?
| Case-Control Studies | 4 | 2015 | 3372 | 0.050 |
Why?
| Pesticides | 1 | 2024 | 58 | 0.050 |
Why?
| Surveys and Questionnaires | 4 | 2019 | 5394 | 0.050 |
Why?
| Caspase 9 | 1 | 2023 | 55 | 0.050 |
Why?
| STAT3 Transcription Factor | 1 | 2025 | 195 | 0.050 |
Why?
| Exercise | 1 | 2014 | 1922 | 0.050 |
Why?
| Prednisone | 1 | 2024 | 232 | 0.050 |
Why?
| Microglia | 1 | 2025 | 232 | 0.050 |
Why?
| Endothelial Cells | 1 | 2008 | 740 | 0.050 |
Why?
| Immunoglobulin M | 1 | 2024 | 275 | 0.050 |
Why?
| DNA Repair | 1 | 1984 | 206 | 0.050 |
Why?
| Virulence | 1 | 2023 | 255 | 0.050 |
Why?
| Lymphocytes | 1 | 1984 | 373 | 0.050 |
Why?
| Energy Metabolism | 1 | 2008 | 869 | 0.050 |
Why?
| Reactive Oxygen Species | 1 | 2025 | 595 | 0.050 |
Why?
| AMP-Activated Protein Kinases | 1 | 2023 | 189 | 0.050 |
Why?
| Hernia, Hiatal | 2 | 2012 | 32 | 0.050 |
Why?
| Liver Cirrhosis | 1 | 2023 | 280 | 0.050 |
Why?
| Colorado | 2 | 2024 | 4412 | 0.050 |
Why?
| Blood Alcohol Content | 1 | 2021 | 5 | 0.050 |
Why?
| Air Pollution | 1 | 2024 | 217 | 0.050 |
Why?
| Ventricular Remodeling | 1 | 2023 | 255 | 0.040 |
Why?
| Ventricular Function, Right | 1 | 2023 | 276 | 0.040 |
Why?
| Environmental Exposure | 1 | 2024 | 463 | 0.040 |
Why?
| United States Department of Veterans Affairs | 1 | 2024 | 635 | 0.040 |
Why?
| Immunoglobulin G | 1 | 2024 | 845 | 0.040 |
Why?
| Firefighters | 1 | 2020 | 39 | 0.040 |
Why?
| Cathelicidins | 1 | 2018 | 37 | 0.040 |
Why?
| Chronic Disease | 2 | 2015 | 1713 | 0.040 |
Why?
| Patient Care Team | 1 | 2024 | 605 | 0.040 |
Why?
| Patient-Centered Care | 1 | 2024 | 504 | 0.040 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2013 | 527 | 0.040 |
Why?
| Half-Life | 1 | 2018 | 162 | 0.040 |
Why?
| California | 1 | 2019 | 401 | 0.040 |
Why?
| Reference Standards | 1 | 2018 | 177 | 0.040 |
Why?
| Age of Onset | 1 | 2019 | 495 | 0.040 |
Why?
| Disease Progression | 2 | 2015 | 2622 | 0.040 |
Why?
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 103 | 0.030 |
Why?
| Dried Blood Spot Testing | 1 | 2017 | 94 | 0.030 |
Why?
| Forkhead Box Protein O3 | 1 | 2016 | 15 | 0.030 |
Why?
| Shock, Septic | 1 | 2019 | 208 | 0.030 |
Why?
| International Classification of Diseases | 1 | 2017 | 122 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2023 | 1705 | 0.030 |
Why?
| Academic Medical Centers | 1 | 2019 | 480 | 0.030 |
Why?
| Propensity Score | 1 | 2017 | 265 | 0.030 |
Why?
| Bronchoalveolar Lavage | 1 | 2015 | 91 | 0.030 |
Why?
| Rats | 3 | 2014 | 5462 | 0.030 |
Why?
| Histocompatibility Antigens Class II | 1 | 2016 | 362 | 0.030 |
Why?
| Self Report | 1 | 2019 | 799 | 0.030 |
Why?
| Psoriasis | 1 | 2015 | 87 | 0.030 |
Why?
| Endocrine System | 1 | 2014 | 20 | 0.030 |
Why?
| Administration, Topical | 1 | 2015 | 145 | 0.030 |
Why?
| Critical Care | 1 | 2019 | 551 | 0.030 |
Why?
| Hemostasis | 1 | 2014 | 79 | 0.030 |
Why?
| Prevalence | 2 | 2011 | 2559 | 0.030 |
Why?
| Anthropometry | 1 | 2014 | 204 | 0.030 |
Why?
| Canada | 1 | 2015 | 347 | 0.030 |
Why?
| Europe | 1 | 2014 | 362 | 0.030 |
Why?
| Pneumonia, Aspiration | 1 | 2013 | 17 | 0.030 |
Why?
| C-Reactive Protein | 1 | 2016 | 400 | 0.030 |
Why?
| Chemokine CCL5 | 1 | 2013 | 43 | 0.030 |
Why?
| Area Under Curve | 1 | 2014 | 304 | 0.030 |
Why?
| Forecasting | 1 | 2015 | 358 | 0.030 |
Why?
| Virus Diseases | 1 | 2015 | 211 | 0.030 |
Why?
| Cross-Sectional Studies | 1 | 2024 | 5057 | 0.030 |
Why?
| Societies, Medical | 1 | 2016 | 747 | 0.030 |
Why?
| Disease Management | 1 | 2016 | 586 | 0.020 |
Why?
| Acute-Phase Proteins | 1 | 2012 | 67 | 0.020 |
Why?
| Calcitonin Gene-Related Peptide | 1 | 2012 | 40 | 0.020 |
Why?
| Gene Expression Regulation | 2 | 2013 | 2543 | 0.020 |
Why?
| Health Surveys | 1 | 2014 | 494 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 2016 | 1424 | 0.020 |
Why?
| Technetium Tc 99m Sulfur Colloid | 1 | 2012 | 6 | 0.020 |
Why?
| Barium Sulfate | 1 | 2012 | 14 | 0.020 |
Why?
| Metabolomics | 1 | 2017 | 652 | 0.020 |
Why?
| Fluorescence | 1 | 2012 | 159 | 0.020 |
Why?
| Gastric Emptying | 1 | 2012 | 40 | 0.020 |
Why?
| Radiopharmaceuticals | 1 | 2012 | 167 | 0.020 |
Why?
| Pregnancy Trimester, First | 1 | 1992 | 138 | 0.020 |
Why?
| Monitoring, Ambulatory | 1 | 2012 | 83 | 0.020 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 1992 | 135 | 0.020 |
Why?
| Esophagitis | 1 | 2011 | 67 | 0.020 |
Why?
| DNA Fragmentation | 1 | 2010 | 44 | 0.020 |
Why?
| bcl-X Protein | 1 | 2010 | 42 | 0.020 |
Why?
| Pneumonia, Viral | 1 | 2015 | 340 | 0.020 |
Why?
| bcl-2-Associated X Protein | 1 | 2010 | 55 | 0.020 |
Why?
| Drug Administration Routes | 1 | 2010 | 38 | 0.020 |
Why?
| Liver Transplantation | 1 | 2018 | 831 | 0.020 |
Why?
| Morbidity | 1 | 2011 | 301 | 0.020 |
Why?
| Membrane Glycoproteins | 1 | 2012 | 473 | 0.020 |
Why?
| Abortion, Induced | 1 | 1992 | 101 | 0.020 |
Why?
| Chromatography, Gel | 1 | 2009 | 127 | 0.020 |
Why?
| Antigens, CD1d | 1 | 2009 | 66 | 0.020 |
Why?
| Radiography | 1 | 2012 | 798 | 0.020 |
Why?
| Reoperation | 1 | 2012 | 543 | 0.020 |
Why?
| Esophagus | 1 | 2011 | 248 | 0.020 |
Why?
| Contrast Media | 1 | 2012 | 391 | 0.020 |
Why?
| T-Lymphocytes, Regulatory | 1 | 1992 | 375 | 0.020 |
Why?
| Cell Movement | 1 | 2013 | 941 | 0.020 |
Why?
| Nursing Assessment | 1 | 2009 | 52 | 0.020 |
Why?
| Transforming Growth Factor beta1 | 1 | 2009 | 157 | 0.020 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 981 | 0.020 |
Why?
| tert-Butyl Alcohol | 1 | 2008 | 1 | 0.020 |
Why?
| Alcohol Dehydrogenase | 1 | 2008 | 16 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 1991 | 457 | 0.020 |
Why?
| Carrier Proteins | 1 | 2012 | 740 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2010 | 767 | 0.020 |
Why?
| Oligopeptides | 1 | 2010 | 256 | 0.020 |
Why?
| Antibodies, Neutralizing | 1 | 2010 | 265 | 0.020 |
Why?
| Collagen | 1 | 2009 | 434 | 0.020 |
Why?
| Cell Hypoxia | 1 | 2008 | 234 | 0.020 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 270 | 0.020 |
Why?
| Body Mass Index | 1 | 2014 | 2267 | 0.020 |
Why?
| Lymphocyte Activation | 1 | 2010 | 1106 | 0.020 |
Why?
| Fibroblasts | 1 | 1991 | 944 | 0.020 |
Why?
| Risk-Taking | 1 | 2009 | 347 | 0.020 |
Why?
| Cell Nucleus | 1 | 2008 | 582 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2010 | 2387 | 0.010 |
Why?
| Pyrazoles | 1 | 2008 | 405 | 0.010 |
Why?
| T-Lymphocytes | 1 | 2013 | 1928 | 0.010 |
Why?
| Testosterone | 1 | 2008 | 371 | 0.010 |
Why?
| Hydroxyurea | 1 | 1984 | 34 | 0.010 |
Why?
| Brain | 1 | 2015 | 2664 | 0.010 |
Why?
| Quality of Life | 1 | 2015 | 2693 | 0.010 |
Why?
| Ultraviolet Rays | 1 | 1984 | 382 | 0.010 |
Why?
| Registries | 1 | 2008 | 1886 | 0.010 |
Why?
| Child, Preschool | 1 | 2014 | 10507 | 0.010 |
Why?
| Child | 1 | 2014 | 20853 | 0.010 |
Why?
| Bleomycin | 1 | 1991 | 244 | 0.010 |
Why?
| Oxygen | 1 | 1991 | 911 | 0.000 |
Why?
| RNA, Messenger | 1 | 1991 | 2702 | 0.000 |
Why?
|
|
Kovacs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|